Evolent Health, Inc. (9EH.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:03AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 3.16B |
| Enterprise value | 3.59B |
| Trailing P/E | N/A |
| Forward P/E | 21.41 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.68 |
| Price/book (mrq) | 3.16 |
| Enterprise value/revenue | 1.83 |
| Enterprise value/EBITDA | -144.67 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.54 |
| 52-week change 3 | -12.35% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 33.00 |
| 52-week low 3 | 22.40 |
| 50-day moving average 3 | 29.51 |
| 200-day moving average 3 | 27.07 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 113.89M |
| Implied shares outstanding 6 | 114.93M |
| Float 8 | 109.13M |
| % held by insiders 1 | 4.17% |
| % held by institutions 1 | 112.30% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -5.76% |
| Operating margin (ttm) | 1.23% |
Management effectiveness
| Return on assets (ttm) | 0.86% |
| Return on equity (ttm) | -10.74% |
Income statement
| Revenue (ttm) | 1.96B |
| Revenue per share (ttm) | 17.65 |
| Quarterly revenue growth (yoy) | 45.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 127.5M |
| Net income avi to common (ttm) | -142.26M |
| Diluted EPS (ttm) | -1.20 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 192.82M |
| Total cash per share (mrq) | 1.69 |
| Total debt (mrq) | 644.8M |
| Total debt/equity (mrq) | 51.74% |
| Current ratio (mrq) | 1.01 |
| Book value per share (mrq) | 9.38 |
Cash flow statement
| Operating cash flow (ttm) | 142.58M |
| Levered free cash flow (ttm) | 172.48M |
© 2024 Yahoo. All rights reserved.